Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jan
20
2023
Where In the World Did My Food Come From: FDA’s Food Traceability Rule Takes Effect ArentFox Schiff LLP
Jan
20
2023
French NGO Claims Certain Everyday Products Contain Unlabeled Nanomaterials Bergeson & Campbell, P.C.
Jan
20
2023
FDA Approval Mifepristone REMS Program Modification Expands Patient Access to Abortion Care Sheppard, Mullin, Richter & Hampton LLP
Jan
20
2023
USDA Expands Generic Label Approval for Meat, Poultry, and Egg Products Keller and Heckman LLP
Jan
19
2023
Preparing a Cannabis Application: Five Things I Learned Bradley Arant Boult Cummings LLP
Jan
18
2023
Congress Enacts Modernization of Cosmetics Regulation Act of 2022, Significantly Strengthening Regulation of Cosmetics Bergeson & Campbell, P.C.
Jan
18
2023
What’s Old Is New Again: Reviving “Fairness” With Renewed FTC Price Discrimination Enforcement And What That Means For Companies Polsinelli PC
Jan
18
2023
Recent Federal Developments in Chemical Law January 2023 Bergeson & Campbell, P.C.
Jan
18
2023
First Major Overhaul of Cosmetics Regulation Since FDR Administration Nelson Mullins
Jan
18
2023
Plaintiffs Allege Failure to Declare Presence of Additives on Sparkling Water Label is Misleading Keller and Heckman LLP
Jan
17
2023
CMS Proposed Rule for Refunding Overpayments Would Align With False Claims Act “Knowledge” Standard Mintz
Jan
17
2023
Is Texas Getting Ready to Expand Its Compassionate Use Program? Bradley Arant Boult Cummings LLP
Jan
17
2023
Court Rules that “Brown Bread” is Not Misleading Keller and Heckman LLP
Jan
17
2023
Prop 65 Roundup - January 2023 ArentFox Schiff LLP
Jan
17
2023
EPA’s Fall 2022 Unified Agenda Includes Proposed and Final TSCA and TRI Rules Bergeson & Campbell, P.C.
Jan
16
2023
Cannabis Lounges Coming to New Jersey Norris McLaughlin P.A.
Jan
13
2023
SweNanoSafe Publishes Notes from Fifth Annual Research Network Workshop Bergeson & Campbell, P.C.
Jan
13
2023
After Almost 25 Years, FTC Issues New Health Products Compliance Guidance McDermott Will & Emery
Jan
13
2023
Lead in your Spice Rack? Womble Bond Dickinson (US) LLP
Jan
13
2023
DEA Chopping Block: DATA-Waiver Requirement Foley & Lardner LLP
Jan
13
2023
FDA’s Center for Food Safety and Applied Nutrition Continues Evaluation of Heavy Metals in Food and Child Development Keller and Heckman LLP
Jan
13
2023
Higher Prices in Pennsylvania and Liquor Law Reform in New Jersey Norris McLaughlin P.A.
Jan
12
2023
USDA Releases Report on State Animal Welfare Policies Keller and Heckman LLP
Jan
11
2023
California Will Soon Protect Employees’ Off-Duty Cannabis Use Greenberg Traurig, LLP
Jan
11
2023
FDA Finalizes FSVP Guidance for Importers of Human and Animal Food Keller and Heckman LLP
Jan
10
2023
Cosmetics Regulations Get a Makeover: Congress Enacts New Requirements Keller and Heckman LLP
Jan
10
2023
Class Action Targets “No Artificial Sweeteners Claim” Keller and Heckman LLP
Jan
10
2023
FDA’s Holiday Present from Congress: Bipartisan Reforms to the Accelerated Approval Framework, Long-Awaited Cosmetic Modernization, and Expansion of Certain Existing Programs Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins